Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
1.
J Chin Med Assoc ; 82(1): 55-59, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30839405

ABSTRACT

BACKGROUND: Hyperkalemia is a risky and potentially life-threatening condition in pre-term infants. Glucose-insulin infusion has been considered a major therapeutic way for non-oligouric hyperkalemia but affects the stability of blood sugar level. We aimed to evaluate the effectiveness of salbutamol nebulization compared to glucose-insulin infusion for the treatment of non-oliguric hyperkalemia in premature infants. METHODS: Forty premature infants (gestation age ≤36 weeks) with non-oliguric hyperkalemia (central serum potassium level greater than 6.0 mmol/L) within 72 h of birth were enrolled in this study. These infants were randomly assigned into two groups. One group received a regular insulin bolus with glucose infusion (Group A; n = 20), and the other received salbutamol (Ventolin) by nebulization (Group B; n = 20). Potassium level, blood sugar, heart rate, and blood pressure were recorded for each group before treatment and at 3, 12, 24, 48, and 72 h post-treatment. RESULTS: The serum potassium levels were reduced after treatment in both groups. No significant changes in heart rate or blood pressure were observed in either group. The fluctuation in glucose levels was gentler in the salbutamol-treated group than in the glucose-insulin infusion group. CONCLUSION: Salbutamol nebulization is not only as effective as glucose-insulin infusion for treating non-oliguric hyperkalemia in premature infants but can avoid potential side effects such as vigorous blood glucose fluctuations.


Subject(s)
Albuterol/administration & dosage , Blood Glucose/analysis , Hyperkalemia/drug therapy , Blood Pressure/drug effects , Double-Blind Method , Heart Rate/drug effects , Humans , Hyperkalemia/blood , Hyperkalemia/physiopathology , Infant, Newborn , Infant, Premature , Nebulizers and Vaporizers , Prospective Studies
2.
Free Radic Res ; 52(9): 970-976, 2018 Sep.
Article in English | MEDLINE | ID: mdl-30037290

ABSTRACT

G72 has been characterised as a susceptibility gene that can have wide-ranging effects in a number of neurodegenerative diseases, including schizophrenia and major depression. Indeed, its product, pLG72, is a potential serum biomarker for schizophrenia. Previous transcriptomic and biochemical studies have indicated that pLG72 may induce the production of mitochondrial reactive oxygen species (ROS), resulting in cell damage. Here, we investigated the mechanism of pLG72 by transfecting a human U87 glioblastoma cell line with a G72 construct. By employing ROS-specific scavengers, we discovered that superoxide radicals were specifically induced in the pLG72-expressing cells. We also found that pLG72 interacted and co-localised with superoxide dismutase 1 (SOD1), resulting in aggregation of SOD1 with a concomitant 23% or 74% reduction of total SOD activity, depending on the amount of G72 transfection plasmid. Finally, we found that transfection of U87 cells with the G72 construct caused a 29% decrease in cell proliferation. The observed loss of SOD1 function in pLG72-expressing cells may explain the elevated ROS levels and inhibition of U87 cell proliferation and has implications for understanding the onset of neurodegenerative diseases in humans.


Subject(s)
Carrier Proteins/genetics , Depressive Disorder, Major/genetics , Schizophrenia/genetics , Superoxide Dismutase-1/genetics , Biomarkers/metabolism , Cell Line, Tumor , Cell Proliferation/genetics , Depressive Disorder, Major/pathology , Humans , Intracellular Signaling Peptides and Proteins , Mitochondria/genetics , Mitochondria/pathology , Protein Aggregation, Pathological/genetics , Reactive Oxygen Species/metabolism , Schizophrenia/pathology , Transfection
3.
PLoS One ; 12(10): e0186486, 2017.
Article in English | MEDLINE | ID: mdl-29036213

ABSTRACT

To determine the feasibility of using a real-time continuous glucose monitoring system (RTGMS) in intensive care units, our study focus on preterm infants with diabetic mothers owing to their high risk of blood sugar abnormalities. Thirty preterm babies (M = 15 and F = 15; ≤ 36 week gestation age) were studied from within 72 hours of delivery. These babies were admitted to the newborn intensive care and were further categorized into groups based on whether their mothers with or without diabetic mellitus. Blood sugar levels were monitored by both RTGMS and the traditional intermittent arterial line (A-Line) glucose method. Continuous glucose monitoring were well tolerated in 30 infants. There were good consistency between RTGMS and A-Line glucose concentration measurements. Of the preterm infants, 33.33% experienced abnormal glucose levels (hypoglycemia or hyperglycemia) between the checkpoint intervals of the intermittent A-Line blood sugar measurements. RTGM showed advantages with regards to reduced pain, greater comfort, the provision of real-time information, high sensitivity (94.59%) and specificity (97.87%) in discovering abnormalities of blood sugar, which are especially valuable for premature infants of diabetic mothers. RTGMS is comparable to A-line measurement for identifying fluctuations in blood glucose in premature infants. RTGMS detects more episodes of abnormal glucose concentration than intermittent A-line blood glucose measurement. High risk infants, especially premature infants with diabetic mothers, should receive more intensive blood sugar level checks by using continuous RTGMS.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus , Infant, Premature/blood , Monitoring, Physiologic/methods , Mothers , Feasibility Studies , Female , Humans , Infant , Infant, Newborn , Intensive Care, Neonatal , Male , Time Factors
4.
J Chin Med Assoc ; 80(8): 487-491, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28709589

ABSTRACT

BACKGROUND: The traditional treatment of subarterial ventricular septal defect (VSD) is open heart surgery. This study aimed to evaluate the feasibility, safety and outcome of transcatheter closure with the Amplatzer duct occluder (ADO). METHODS: Between March 2012 and June 2015, a total of 16 patients (8 male and 8 female) with subarterial VSD who underwent transcatheter closure with the ADO were enrolled retrospectively. Their age ranged from 3.0 to 65.6 years, with the median of 35.6 years; their body weights ranged from 14 to 92 kg with the median of 60 kg. All patients had prolapse of the right coronary cusp without subaortic rim. Mild aortic regurgitation was noted in 11 (69%) patients. RESULTS: Left ventriculogram showed VSD size ranged from 1.3 to 9.3 mm with the median of 3.5 mm. The device was successfully implanted in 88% (14/16) of the patients. Although one patient had mild skin allergy to contrast medium, no other complication was noted. Complete closure rate was 64%, 86%, 86% and 86% at 1-day, 1-month, 6-month and 12-month follow-up, respectively. Two patients developed new or worsening aortic regurgitation during follow-up. CONCLUSION: Transcatheter closure of subarterial VSD with ADO is technically feasible and safe in patients older than 7 years of age. However, development or worsening of aortic regurgitation requires long-term follow-up.


Subject(s)
Heart Septal Defects, Ventricular/surgery , Septal Occluder Device , Adolescent , Adult , Aged , Cardiac Catheterization , Child , Child, Preschool , Female , Humans , Male , Middle Aged , Retrospective Studies , Septal Occluder Device/adverse effects , Young Adult
5.
Curr Med Res Opin ; 33(11): 2019-2025, 2017 11.
Article in English | MEDLINE | ID: mdl-28498027

ABSTRACT

BACKGROUND: The etiology of herniated intervertebral disc (HIVD) disease in children and adolescents is multifactorial and not merely related to disc degeneration. Therefore, in the present study, we investigated the relationship between young asthma patients and the risk of early HIVD disease in a population under 30 years of age. METHODS: Data from the National Health Insurance Research Database (NHIRD) of Taiwan were used to conduct a retrospective longitudinal cohort study. The study cohort comprised 23,470 patients with asthma (asthma group) and 23,470 patients without asthma (non-asthma group), who were selected through frequency matching on the basis of sex, age, and the index year. The study patients were followed until HIVD disease occurrence, withdrawal from the National Health Insurance program, or 31 December 2013. Cox proportional hazards regression analysis was conducted to assess the risk of HIVD disease in the asthma group after adjustment for sex, age, and comorbidities. RESULTS: After adjustment for sex, age, and comorbidities, the asthma group had a 1.69-fold (95% confidence interval [CI] = 1.29-2.23) higher risk of HIVD disease than did the non-asthma group. In addition, the asthma group had a higher risk of cervical and lumbar HIVD diseases than did the non-asthma group (adjusted hazard ratio [HR] = 2.38; 95% CI = 1.25-4.57 and adjusted HR = 1.56; 95% CI = 1.15-2.12, respectively). CONCLUSIONS: Young patients with asthma are at a significantly higher risk of early cervical or lumbar HIVD disease.


Subject(s)
Asthma/epidemiology , Intervertebral Disc Degeneration/etiology , Intervertebral Disc Displacement/etiology , Adolescent , Child , Child, Preschool , Cohort Studies , Female , Humans , Male , Proportional Hazards Models , Retrospective Studies , Risk , Risk Factors , Taiwan/epidemiology
6.
Acta Paediatr Taiwan ; 44(6): 368-71, 2003.
Article in English | MEDLINE | ID: mdl-14983661

ABSTRACT

Solid cystic pseudopapillary tumors of the pancreas (Frantz's tumor) are rare in children. We present a 12-year-old child with a pancreatic tumor without initial symptoms or signs until the tumor compressed the adjacent organs. The child had clinical presentation of intermittent abdominal cramping pain, vomiting, changes in bowel habits and decreased of appetite for 2 days. The abdominal computed tomography showed a mass that measuring 6 x 7 x 7 cm at the right upper quadrate. Whipple operations with pylorus-preserved pancreato-duodenectomy and cholecystectomy were performed. The definite diagnosis was made by the post-operation pathological finding. Grossly, the tumor was encapsulated with cystic degeneration and hemorrhagic necrosis appearance. Microscopically, it had predominantly papillary arrangement mixed with solid areas. Prognosis of this tumor was good under complete resection. The patient remained well with no signs of recurrence or malignant changes at 1 year after operation. Due to the possibility of recurrence, close follow up is recommended.


Subject(s)
Cystadenoma, Papillary , Pancreatic Neoplasms , Child , Cystadenoma, Papillary/pathology , Cystadenoma, Papillary/surgery , Female , Humans , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL